Afficher la notice abrégée

dc.rights.licenseopenen_US
dc.contributor.authorMOUFFAK, Amelle
dc.contributor.authorLEPELLEY, Marion
dc.contributor.authorREVOL, Bruno
dc.contributor.authorBERNARDEAU, Claire
hal.structure.identifierBordeaux population health [BPH]
dc.contributor.authorSALVO, Francesco
hal.structure.identifierBordeaux population health [BPH]
dc.contributor.authorPARIENTE, Antoine
IDREF: 13395711X
dc.contributor.authorROUSTIT, Matthieu
dc.contributor.authorCRACOWSKI, Jean-Luc
dc.contributor.authorKHOURI, Charles
dc.date.accessioned2021-08-23T08:58:38Z
dc.date.available2021-08-23T08:58:38Z
dc.date.issued2021-06-26
dc.identifier.issn0895-4356en_US
dc.identifier.urihttps://oskar-bordeaux.fr/handle/20.500.12278/110187
dc.description.abstractEnOBJECTIVE: To systematically review and appraise misinterpretation of pharmacovigilance disproportionality analysis results in published studies. STUDY DESIGN AND SETTING: We randomly selected 100 studies that performeddisproportionality analysesand indexed in Medline identified during a systematic literature search. Titles, abstracts and main texts (results, discussion and conclusion) were evaluated for spin independently by 2 reviewers. Spin in pharmacovigilance studies was classified according to 3 main categories: inappropriate interpretation, inappropriate extrapolations and misleading reporting. RESULTS: Of the 100 studies evaluated, we found that 63%, 56% and 51% had at least one type of spin in their abstract, main text or conclusion respectively, and 40%used causal language to interpret their results in the abstract or conclusion.Spin in titles and results were exclusively represented by inappropriate interpretations of findings (12% and 21% respectively), with terms such as "risk of" or "risks associated with" or results erroneously presented as regular Odds Ratios. Spin in discussion sections mostly concernedinappropriate interpretations (38%)and misleading reporting (12%). Misleading reporting, notably failing to acknowledge the limitations of disproportionality analyses, was the most frequent type of spin in abstracts (55%) and conclusion sections (37%). CONCLUSION: We found that spin is frequent in publications of pharmacovigilance disproportionality analyses, notably in abstracts.This consisted notably in an over-interpretation of the results suggesting a proven causative link between a drug use and the risk of an event.
dc.language.isoENen_US
dc.subject.enPharmacovigilance
dc.subject.enDisproportionality analyses
dc.subject.enSignal detection
dc.subject.enSpin
dc.subject.enReporting
dc.title.enHigh prevalence of spin was found in pharmacovigilance studies usingdisproportionality analyses todetectsafetysignals: a meta-epidemiologicalstudy: Spin in pharmacovigilance disproportionality analyses
dc.typeArticle de revueen_US
dc.identifier.doi10.1016/j.jclinepi.2021.06.022en_US
dc.subject.halSciences du Vivant [q-bio]/Santé publique et épidémiologieen_US
dc.identifier.pubmed34186195en_US
bordeaux.journalJournal of Clinical Epidemiologyen_US
bordeaux.page73-79en_US
bordeaux.volume138en_US
bordeaux.hal.laboratoriesBordeaux Population Health Research Center (BPH) - UMR 1219en_US
bordeaux.institutionUniversité de Bordeauxen_US
bordeaux.institutionINSERMen_US
bordeaux.teamPharmacoEpi-Drugsen_US
bordeaux.peerReviewedouien_US
bordeaux.inpressnonen_US
hal.identifierhal-03323982
hal.version1
hal.date.transferred2021-08-23T08:58:42Z
hal.exporttrue
bordeaux.COinSctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.jtitle=Journal%20of%20Clinical%20Epidemiology&rft.date=2021-06-26&rft.volume=138&rft.spage=73-79&rft.epage=73-79&rft.eissn=0895-4356&rft.issn=0895-4356&rft.au=MOUFFAK,%20Amelle&LEPELLEY,%20Marion&REVOL,%20Bruno&BERNARDEAU,%20Claire&SALVO,%20Francesco&rft.genre=article


Fichier(s) constituant ce document

FichiersTailleFormatVue

Il n'y a pas de fichiers associés à ce document.

Ce document figure dans la(les) collection(s) suivante(s)

Afficher la notice abrégée